Goodwin Charles D. II 4
4 · Apyx Medical Corp · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Goodwin Charles D. II
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-01-29+121,500→ 121,500 totalExercise: $9.29From: 2024-01-29Exp: 2031-01-29→ Common Stock (121,500 underlying)
Footnotes (1)
- [F1]Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.